vimarsana.com
Home
Live Updates
SK life science Presents Latest Data on XCOPRI® (cenoba
SK life science Presents Latest Data on XCOPRI® (cenoba
SK life science Presents Latest Data on XCOPRI® (cenobamate tablets) CV in Adults with Partial-Onset (Focal) Seizures at the AES 2022 Annual Meeting
/PRNewswire/ -- SK Life Science, Inc., a subsidiary of SK Biopharmaceuticals Co., Ltd., an innovative global pharmaceutical company focused on developing...
Related Keywords
China ,
Japan ,
United States ,
Canada ,
United Kingdom ,
American ,
Angelini Pharma ,
Prnewswire Sk Life Science Inc ,
Sk Group ,
Source Sk Life Science Inc ,
Sk Biopharmaceuticals Co Ltd ,
American Epilepsy Society ,
Epilepsy Foundation ,
Sk Inc ,
Sk Life Science Inc ,
European Union ,
Sudden Unexpected Death ,
Annual Meeting ,
Responder Rates Over ,
Ono Pharmaceutical ,
Ignis Therapeutics ,
Greater China ,
Familial Short ,
North American Antiepileptic Drug ,
Post Hoc Analysis ,
Open Label Study ,
Epilepsy During ,
Cenobamate Clinical Development Program ,
Who Gets ,
Accessed March ,
Sk Life Science ,
Nc ,